FILE PHOTO: A healthcare worker gives a dose of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, to a woman inside a classroom of a school, which has been converted into a temporary vaccination centre, in New Delhi, India, May 4, 2021. REUTERS/Adnan Abidi
NEW DELHI (Reuters) - India's main opposition party, Congress, on Wednesday questioned the decision by Prime Minister Narendra Modi's government to double the gap between the doses of the AstraZeneca COVID-19 vaccine, asking whether it was prompted by a vaccine shortage.
On Tuesday, Reuters reported that the government had increased the gap without the agreement of the scientific group that it said recommended the move, citing three members of the National Technical Advisory Group on Immunisation (NTAGI) advisory body.
Limited time offer:
Just RM5 per month.
